Aims & Scope
Toxicon has an open access mirror Toxicon: X, sharing the same aims and scope, editorial team, submission system and rigorous peer review.
An introductory offer Toxicon: X - full waiver of the Open Access fee.
Toxicon's "aims and scope" are to publish: -articles containing the results of original research on problems related to toxins derived from animals, plants and microorganisms -papers on novel findings related to the chemical, pharmacological, toxicological, and immunological properties of natural toxins -molecular biological studies of toxins and other genes from poisonous and venomous organisms that advance understanding of the role or function of toxins -clinical observations on poisoning and envenoming where a new therapeutic principle has been proposed or a decidedly superior clinical result has been obtained. -material on the use of toxins as tools in studying biological processes and material on subjects related to venom and antivenom problems. -articles on the translational application of toxins, for example as drugs and insecticides -epidemiological studies on envenoming or poisoning, so long as they highlight a previously unrecognised medical problem or provide insight into the prevention or medical treatment of envenoming or poisoning.
Retrospective surveys of hospital records, especially those lacking species identification, will not be considered for publication.
Properly designed prospective community-based surveys are strongly encouraged. -articles describing well-known activities of venoms, such as antibacterial, anticancer, and analgesic activities of arachnid venoms, without any attempt to define the mechanism of action or purify the active component, will not be considered for publication in Toxicon. -review articles on problems related to toxinology.
To encourage the exchange of ideas, sections of the journal may be devoted to Short Communications, Letters to the Editor and activities of the affiliated societies.
View Aims & ScopeMetrics & Ranking
Impact Factor
| Year | Value |
|---|---|
| 2025 | 2.4 |
| 2024 | 2.60 |
SJR (SCImago Journal Rank)
| Year | Value |
|---|---|
| 2024 | 0.527 |
Quartile
| Year | Value |
|---|---|
| 2024 | Q3 |
h-index
| Year | Value |
|---|---|
| 2024 | 148 |
Journal Rank
| Year | Value |
|---|---|
| 2024 | 11037 |
Journal Citation Indicator
| Year | Value |
|---|---|
| 2024 | 1978 |
Impact Factor Trend
Abstracting & Indexing
Journal is indexed in leading academic databases, ensuring global visibility and accessibility of our peer-reviewed research.
Subjects & Keywords
Journal’s research areas, covering key disciplines and specialized sub-topics in Pharmacology, Toxicology and Pharmaceutics, designed to support cutting-edge academic discovery.
Most Cited Articles
The Most Cited Articles section features the journal's most impactful research, based on citation counts. These articles have been referenced frequently by other researchers, indicating their significant contribution to their respective fields.
-
Mode of action of Bacillus thuringiensis Cry and Cyt toxins and their potential for insect control
Citation: 1042
Authors: Alejandra, Sarjeet S., Mario
-
Snake venom variability: methods of study, results and interpretation
Citation: 577
Authors: J.-P., V., J.
-
Excitement ahead: structure, function and mechanism of snake venom phospholipase A2 enzymes
Citation: 544
Authors: R
-
Voltage-gated ion channels and gating modifier toxins
Citation: 536
Authors: William A., Sandrine, Vladimir, Frank H., Keiichi, Todd
-
Podophyllotoxin: distribution, sources, applications and new cytotoxic derivatives
Citation: 476
Authors: M, P.A, J.M, M.A, M.A
-
Structural considerations of the snake venom metalloproteinases, key members of the M12 reprolysin family of metalloproteinases
Citation: 459
Authors: Jay W., Solange M.T.